Hormone Receptor Positive Tumor Recruiting Phase 2 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03809988PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)Treatment
NCT03906669A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.Treatment
NCT03874325Aromatase Inhibitor and Durvalumab in Postmenopausal Breast CancerTreatment